Suchergebnisse - "Michael Mauro"

1

Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations

von: Elisabetta Abruzzese

2020, in: Therapeutic Advances in Hematology

Wird geladen...
2

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase

von: Valentin García-Gutiérrez

2022, in: Journal of Hematology & Oncology

Wird geladen...
3

Three-Dimensional Analysis of Round Window Membrane in the Chinchilla Model with Acute Otitis Media Induced with Streptococcus Pneumoniae 7F

von: Nevra Keskin Yılmaz

2021, in: Turkish Archives of Otorhinolaryngology

Wird geladen...
4

Identification of Conserved MEL-28/ELYS Domains with Essential Roles in Nuclear Assembly and Chromosome Segregation.

von: Georgina Gómez-Saldivar

2016, in: PLoS Genetics

Wird geladen...
5

P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

von: Ehab Atallah

2023, in: HemaSphere

Wird geladen...
6

P665: RAPID AND DEEP RESPONSES WITH ASCIMINIB IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS (TKIS) IN THE PHASE 3 ASCEMBL STUDY

von: Timothy Hughes

2023, in: HemaSphere

Wird geladen...
7

P662: POST HOC ANALYSIS OF PATIENT RESPONSES BY T315I MUTATION STATUS FROM THE 3-YEAR UPDATE OF THE OPTIC TRIAL: A DOSE-OPTIMIZATION STUDY OF 3 STARTING DOSES OF PONATINIB

von: Jorge Cortes

2023, in: HemaSphere

Wird geladen...
8

Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

von: James L. Januzzi

2022, in: Journal of Hematology & Oncology

Wird geladen...
9

Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee

von: James L. Januzzi

2022, in: Journal of Hematology & Oncology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!